This website is intended for healthcare professionals
This website is intended for healthcare professionals
A new study led by scientists in Japan analysed the microbiota of people living with Parkinson's, as well as those without, and noted that those with the disease have notably fewer bacterial genes...
The landmark UK prospective diabetes glucose-control studies carried out over 20 years, with data from 1977 to 1997 and published in 1998 were the first to show that complications from diabetes are...
In the UK, there are currently five fluoroquinolones licensed for use, which can be taken orally, given intravenously or via inhalation. These include the most common, ciprofloxacin, which is used to...
Cardiac arrhythmias represent a significant burden, affecting morbidity and mortality (Gheorghe-Andrei et al, 2018). Atrial fibrillation (AF) is the most common arrhythmia, and prevalence not only...
Eli Lilly (2023) created donanemab, noting last year that 47% of participants taking the medication had no clinical progression at one year of the disease. However, the placebo group also had no...
‘Prescribers should become aware of the characteristics of the setting in which they work, and be conscious of how this may influence communication and patient interactions’.
Duncan et al (2016) published a study in the BMJ Open, which evaluated trends in the prescribing of quetiapine to adults in the Canadian province of Alberta between 2008 and 2013.
A tool has been developed that requires a health professional to carry out the assessment (Lauridsen et al, 2022). A UTI risk factor model was used as the basis to inform the content included in the...
A study published late last year in the British Medical Journal (Wang et al, 2022) evaluated the association between the initiation of fluoroquinolones and admissions to hospitals or emergency...
Sotomi et al (2023) examine the use of machine learning to identify cohorts of a population that may benefit from specific medications. The team had previously established a machine learning-based...
Diabetes UK (2023), together with the American Diabetes Association and the European Association for the Study of Diabetes, defines remission as HbA1c levels remaining below 48 mmol/mol or 6.5% for...
A new study published in the British Medical Journal has examined whether the use of the receptor agonist glucagon-like peptide 1 (GLP-1), dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose...
As we make our way through cold and flu season, prescribers are likely to encounter many patients with varying degrees of illness from these viruses..
In 2021, the British Thoracic Society (BTS, 2022) carried out a national audit of the management of tobacco dependency in acute care trusts, following previous audits in 2019 and 2016. The audit...
The New England Journal of Medicine recently published the results of a study examining the efficacy of tirzepatide—a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1...
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills